Search
Login
Register
Menu
BJMO
Home
News
CongressUpdate
Guidelines
Cancertrials
Specials
Patients
News
Oncopedia
All
All
BJMO articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Journal issues
>
Volume 10, Immuno-Oncology Special Edition, 2016
Volume 10, Immuno-Oncology Special Edition, 2016
Volume 10, Immuno-Oncology Special Edition, 2016
Previous issue
Next issue
All issues
Subscribe
Interactive PDF
Quickly to
REVIEW ONCOLOGY
PRACTICE GUIDELINES
PHARMACOTHERAPY
RESEARCH
ONCOCASE
ONCOTHESIS
ONCOQUIZ
PHARMACO-ECONOMICS
CONGRESS NEWS
REIMBURSEMENT NEWS
LETTER TO THE EDITOR
Index
SPECIAL
The CTLA-4 and PD-1/PD-L1 pathways: leading the way in cancer immunotherapy
T. Feys
Immuno-oncology in lung cancer
P. Germonpré, J. Lamont
How immune checkpoint inhibition reshaped advanced melanoma
J.F. Baurain
Broadening the possibilities for checkpoint inhibitors
T. Feys
Immune checkpoint inhibitors in clinical practice: management of immune-related toxicities
B. Neyns
The financial toxicity of cancer immunotherapy
P. Specenier
Top
